Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending June 12 2022

Healthcare Private Placement and M&A Transactions Review Week Ending June 12 2022

by Jonathan Hodson-Walker | Jun 15, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Owkin: The company raised $80 million of Series B1 venture funding in a deal led by Bristol-Myers Squibb on June 9, 2022. The company is a developer of machine learning tools designed to augment...
Healthcare Private Placement and M&A Transactions Review Week Ending June 5 2022

Healthcare Private Placement and M&A Transactions Review Week Ending June 5 2022

by Jonathan Hodson-Walker | Jun 7, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Diabeloop: The company raised EUR 70 million of Series C venture funding in a deal led by LBO France on June 2, 2022, putting the company’s pre-money valuation at an estimated EUR 253.34...
Healthcare Private Placement and M&A Transactions Review Week Ending May 29 2022

Healthcare Private Placement and M&A Transactions Review Week Ending May 29 2022

by Jonathan Hodson-Walker | Jun 2, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions ProFound Therapeutics: The company raised $75 million of venture funding from Flagship Pioneering on May 26, 2022. The company is a developer of a platform intended to discover expanded human...
Healthcare Private Placement and M&A Transactions Review Week Ending May 22 2022

Healthcare Private Placement and M&A Transactions Review Week Ending May 22 2022

by Jonathan Hodson-Walker | May 24, 2022 | Healthcare

Private Placement Transactions: Remix Therapeutics: The company raised $70 million of Series B venture funding from Alexandria Venture Investments, Foresite Capital Management and Atlas Venture on May 17, 2022, putting the company’s pre-money valuation at $150...
Healthcare Private Placement and M&A Transactions Review Week Ending May 15 2022

Healthcare Private Placement and M&A Transactions Review Week Ending May 15 2022

by Jonathan Hodson-Walker | May 17, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Domain Therapeutics: The company raised EUR 39 million of Series A venture funding in a deal led by Panacea Venture, CTI Life Sciences Fund and 3B Future Health Ventures on May 10, 2022. adMare...
Healthcare Private Placement and M&A Transactions Review Week Ending May 8 2022

Healthcare Private Placement and M&A Transactions Review Week Ending May 8 2022

by Jonathan Hodson-Walker | May 10, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Hello Heart: The company raised $70.00 million of Series D venture funding in a deal led by Stripes on May 2, 2022, putting the company’s pre-money valuation at $530.00 million. Resolute...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives